Scott Alexander, curated
← Back to curation

Is There A Case For Skepticism Of Psychedelic Therapy?

Quality
70
Strong
Claude Shift
46
Moderate
RWI
2
of 10

Summary

A sharp, prescient skeptical case against the psychedelic-therapy hype, from someone who explicitly hopes it works. Seven reasons: (1) the field is small studies run by true believers -- prime conditions for unreplicable results (the 5-HTTLPR comparison; the exciting psilocybin-raises-Openness study already failed to replicate); (2) psychotherapy success stories are cheap (Freud got glowing ones too); (3) ketamine is the best comparison -- hyped as revolutionary, now in common use, abysmal FDA studies, not actually revolutionary; (4) NSI-189 -- same hype-and-anecdote cycle, failed FDA trials; (5) 10-50% of Americans have tried psychedelics, so if they did something shocking we'd already know (he knows heavy users who are still nervous wrecks); (6) his model -- psychedelics artificially stimulate the 'insight system' the way heroin stimulates the happiness system, producing a false sense of profundity (cf. 'Universal Love, Said The Cactus Person'); (7) even if they work, the FDA will kill them with a thousand paper cuts (the esketamine precedent: $600, weird route, specialized clinics). Clear-eyed, fair, and well-aged (psychedelic therapy has indeed met replication and regulatory headwinds). NOTE: this INVOKES the replication crisis as grounds for skepticism rather than relying on shaky findings, so no replication caveat applies.

Why this score

Quality 70 · Strong. Strong (70): a sharp, prescient, well-structured skeptical case that injects needed rigor into a hype-dominated topic, with a genuinely good original model (insight-system stimulation -> false profundity) and foresighted FDA/replication points. Upper-Strong rather than higher because it's a relatively short, listicle-format argument rather than a deep investigation.

Claude’s paradigm shift 46 · Moderate. Moderate (46): the systematic skeptical case and especially the 'psychedelics stimulate the insight system' model are a fresh, valuable contribution against the prevailing enthusiasm, though built from standard replication-crisis and hype-cycle reasoning.

Real-world impact 2 · Minor. A prescient skeptical case against psychedelic-therapy hype; injected rigor into the discourse around a consequential medical topic but did not itself alter clinical practice, regulation, or patient outcomes → RWI 2.